Alk-Abello A/S header image

Alk-Abello A/S

ALK B

Equity

ISIN DK0061802139 / Valor 117689788

Nasdaq Copenhagen Equities (2026-03-03)
DKK 215.00-2.09%

Alk-Abello A/S
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Alk-Abello A/S is a Danish pharmaceutical company specializing in the development and production of allergy immunotherapy products. The company is committed to advancing long-term allergy treatment and aims to establish a leading position in the management of food allergies and anaphylaxis. Alk-Abello's strategic focus includes expanding its portfolio of respiratory allergy tablets and enhancing its pediatric coverage. The company is also exploring partnerships to accelerate the commercial adoption of its products across various markets. By prioritizing innovation and optimizing its operations, Alk-Abello seeks to address unmet needs in adjacent allergic conditions. The company emphasizes cultivating its organizational capabilities to foster a high-performance culture and improve access to allergy care.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

42.5%1Y
102%3Y
68.8%5Y

Performance

29.2%1Y
37.7%3Y
37.4%5Y

Volatility

Market cap

6740 M

Market cap (USD)

Daily traded volume (Shares)

258,046

Daily traded volume (Shares)

1 day high/low

161.3 / 157.9

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Conmed Corp
Conmed Corp Conmed Corp Valor: 920278
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.20%USD 43.41
National Healthcare Corp
National Healthcare Corp National Healthcare Corp Valor: 836282
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.37%USD 170.51
Dexcom Inc
Dexcom Inc Dexcom Inc Valor: 2107726
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.95%USD 73.08
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.38%USD 182.64
Insulet Corp
Insulet Corp Insulet Corp Valor: 2941247
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.47%USD 241.84
Henry Schein Inc
Henry Schein Inc Henry Schein Inc Valor: 83527
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.43%USD 80.21
NovoCure Limited
NovoCure Limited NovoCure Limited Valor: 29570025
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.63%USD 13.30
Roivant Sciences Limited
Roivant Sciences Limited Roivant Sciences Limited Valor: 113331044
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.89%USD 27.85
Integra Lifesciences Holdings Corp
Integra Lifesciences Holdings Corp Integra Lifesciences Holdings Corp Valor: 912247
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.25%USD 10.56
ICU Medical Inc
ICU Medical Inc ICU Medical Inc Valor: 940704
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.95%USD 142.66